Allergic bronchopulmonary aspergillosis in India
Clinical & Experimental Allergy · 2023
DOI: 10.1111/cea.14319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, 2023. Verfasst von Ritesh Agarwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Asthma, Cystic Fibrosis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 128 Literaturangaben.
Abstract (Originalsprache)
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune‐mediated reactions mounted against Aspergillus fumigatus . The disorder most commonly complicates the course of patients with asthma and cystic fibrosis. From its first description in 1952, significant advances have been made in understanding the pathogenesis and the diagnosis and treatment of ABPA. In the last two decades, most research on ABPA has been published from India. The prevalence and clinical presentation may differ in India from that reported elsewhere. Herein, we review the epidemiology, clinical and radiological characteristics, and distinctive features of ABPA in the Indian subcontinent. To support the review, we surveyed pulmonologists nationwide to understand the challenges in diagnosing and managing ABPA. The survey has yielded valuable insights into the practices associated with the diagnosis and management of ABPA in India.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Pulmonology, CK Birla Hospitals, Kolkata, India.
- Department of Infectious Disease, Faculty of Medicine, Imperial College, London, UK.
ORCID-Profile: Ritesh Agarwal
Zitieren
APA
Agarwal, R., Sehgal, I. S., Muthu, V., Dhar, R., & Armstrong-James, D. (2023). Allergic bronchopulmonary aspergillosis in India. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14319
Vancouver
Agarwal R, Sehgal IS, Muthu V, Dhar R, Armstrong-James D. Allergic bronchopulmonary aspergillosis in India. Clinical & Experimental Allergy. 2023. doi:10.1111/cea.14319
BibTeX
@article{Agarwal2023,
author = {Agarwal, Ritesh and Sehgal, Inderpaul Singh and Muthu, Valliappan and Dhar, Raja and Armstrong-James, Darius},
title = {Allergic bronchopulmonary aspergillosis in India},
journal = {Clinical & Experimental Allergy},
year = {2023},
doi = {10.1111/cea.14319}
}
EUVIMED